4-chloro-2-(4-(trifluoromethyl)phenyl)-3H-imidazo[4,5-g]quinoline

ID: ALA3809002

PubChem CID: 127044120

Max Phase: Preclinical

Molecular Formula: C17H9ClF3N3

Molecular Weight: 347.73

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  FC(F)(F)c1ccc(-c2nc3cc4cccnc4c(Cl)c3[nH]2)cc1

Standard InChI:  InChI=1S/C17H9ClF3N3/c18-13-14-10(2-1-7-22-14)8-12-15(13)24-16(23-12)9-3-5-11(6-4-9)17(19,20)21/h1-8H,(H,23,24)

Standard InChI Key:  YSAMNUSNKSSPOT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
    4.6043   -0.6682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6043    0.8382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3044    1.5915    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3044   -1.4214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9924   -0.6682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9924    0.8382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7168    1.5915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7168   -1.4214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5831   -0.6682    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5831    0.8382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0045    1.2999    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8792    0.0850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0045   -1.1298    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.3799    0.0850    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2183   -1.1531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.7144   -1.0449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.3687    0.3048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5270    1.5464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0309    1.4382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -8.8657    0.4131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -9.5397   -0.5798    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -9.3888    1.4930    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  -10.0625    0.5002    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.7217    2.7914    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
  7 24  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3809002

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 347.73

Molecular Weight (Monoisotopic): 347.0437

AlogP: 5.45

#Rotatable Bonds: 1

Polar Surface Area: 41.57

Molecular Species: NEUTRAL

HBA: 2

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 3

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 10.28

CX Basic pKa: 5.06

CX LogP: 4.92

CX LogD: 4.92

Aromatic Rings: 4

Heavy Atoms: 24

QED Weighted: 0.50

Np Likeness Score: -1.28

References

1. Carta A, Briguglio I, Piras S, Corona P, Ibba R, Laurini E, Fermeglia M, Pricl S, Desideri N, Atzori EM, La Colla P, Collu G, Delogu I, Loddo R..  (2016)  A combined in silico/in vitro approach unveils common molecular requirements for efficient BVDV RdRp binding of linear aromatic N-polycyclic systems.,  117  [PMID:27161176] [10.1016/j.ejmech.2016.03.080]

Source

Source(1):

• Scientific Literature